ArticleFrontiers in psychology2026
A randomised controlled study of dog assisted therapy: comparing a short and a long version for patients with fetal alcohol spectrum disorder.
Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06763614 (A Randomised Controlled Study of Dog Assisted Therapy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomised Controlled Study of Dog Assisted Therapy: Comparing a Short and a Long Version Program for Patients with Fetal Alcohol Spectrum Disorder.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fetal Alcohol Spectrum Disorder (FASD) presents with complex neurodevelopmental challenges, including emotional, behavioral, and social difficulties. Dog-Assisted Therapy (DAT) has shown potential benefits, but optimal duration for maximal efficacy remains unclear. Objective: The present randomised controlled trial aimed to compare the therapeutic impact of a short version (8 weekly sessions) versus a long version (16 sessions) of a manualised DAT protocol on clinical, functional, and family outcomes in children and adolescents with FASD. Methods: Sixty-four participants were randomised to the short or long DAT version, with 55 completing treatment. Primary outcomes included social skills, internalizing and externalizing symptom profiles, quality of life, clinical severity, and parental anxiety and depression. Results: Both groups showed significant improvements across externalizing symptoms, social skills, FASD severity, and quality of life. However, the long-version DAT group exhibited greater reductions in externalizing symptoms (CBCL Inattention: Clinical trial registration: clinicaltrials.gov, NCT06763614.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.